These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29468984)

  • 1. VaD - An Integrated Framework for Cognitive Rehabilitation.
    Balea M; Muresanu D; Alvarez A; Homberg V; Bajenaru O; Guekht A; Heiss WD; Popa L; Vester J; Muresanu I; Birle C; Slavoaca D
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):22-33. PubMed ID: 29468984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB
    CNS Drugs; 2017 Sep; 31(9):759-776. PubMed ID: 28786085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia.
    Yang T; Zhang F
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):97-116. PubMed ID: 33054394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards Combinatorial Approaches for Preserving Cognitive Fitness in Aging.
    Brem AK; Sensi SL
    Trends Neurosci; 2018 Dec; 41(12):885-897. PubMed ID: 30343822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness].
    Levada OA; Traïlin AV
    Lik Sprava; 2012; (3-4):53-9. PubMed ID: 23356138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
    Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L
    Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia with cerebrovascular disease: the benefits of early treatment.
    Schindler RJ
    Eur J Neurol; 2005 Oct; 12 Suppl 3():17-21. PubMed ID: 16144533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bee Venom Ameliorates Cognitive Dysfunction Caused by Neuroinflammation in an Animal Model of Vascular Dementia.
    Cai M; Lee JH; Yang EJ
    Mol Neurobiol; 2017 Oct; 54(8):5952-5960. PubMed ID: 27686075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivastigmine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004744. PubMed ID: 15846730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive morphometric and cognitive changes in vascular dementia.
    Gunstad J; Brickman AM; Paul RH; Browndyke J; Moser DJ; Ott BR; Gordon N; Haque O; Cohen RA
    Arch Clin Neuropsychol; 2005 Mar; 20(2):229-41. PubMed ID: 15708732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The many faces of vascular cognitive impairment.
    Girouard H; Munter LM
    J Neurochem; 2018 Mar; 144(5):509-512. PubMed ID: 29430652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.